30th Apr 2007 15:07
AGI Therapeutics plc30 April 2007 30 April 2007 AGI Therapeutics plc ("AGI" or the "Company") Directors' Dealing The Company was informed on 30 April 2007 that on 27 April 2007 Ronan Lambe, nonexecutive chairman of AGI, acquired 400,000 ordinary shares of €0.01 each ("Ordinary Shares") in the share capital of the Company at a price of €1.80 perOrdinary Share. Following this trade, Ronan Lambe has an interest in 1,296,825Ordinary Shares representing approximately 1.92% of the Company's issued sharecapital. In addition, the Company was informed on 30 April 2007 that on 27 April 2007Mary Martin, an executive director of AGI, disposed of 300,000 Ordinary Sharesthe Company at a price of €1.80 per Ordinary Share. Following this trade, MaryMartin has an interest in 1,113,489 Ordinary Shares representing approximately1.65% of the Company's issued share capital. Contact Information: David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254 This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai